Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Return on Invested Capital: 2014-2017

Historic Return on Invested Capital for Tvardi Therapeutics (TVRD) over the last 4 years, with Sep 2017 value amounting to -0.64%.

  • Tvardi Therapeutics' Return on Invested Capital fell 5.00% to -0.64% in Q3 2017 from the same period last year, while for Sep 2017 it was -0.64%, marking a year-over-year decrease of 5.00%. This contributed to the annual value of -0.74% for FY2016, which is 43.00% down from last year.
  • As of Q3 2017, Tvardi Therapeutics' Return on Invested Capital stood at -0.64%, which was up 32.41% from -0.95% recorded in Q2 2017.
  • Tvardi Therapeutics' Return on Invested Capital's 5-year high stood at -0.20% during Q2 2014, with a 5-year trough of -1.73% in Q1 2017.
  • In the last 3 years, Tvardi Therapeutics' Return on Invested Capital had a median value of -0.47% in 2015 and averaged -0.63%.
  • In the last 5 years, Tvardi Therapeutics' Return on Invested Capital rose by 11bps in 2015 and then crashed by 143bps in 2017.
  • Tvardi Therapeutics' Return on Invested Capital (Quarterly) stood at -0.33% in 2014, then climbed by 11bps to -0.23% in 2015, then tumbled by 72bps to -0.95% in 2016, then decreased by 5bps to -0.64% in 2017.
  • Its Return on Invested Capital was -0.64% in Q3 2017, compared to -0.95% in Q2 2017 and -1.73% in Q1 2017.